Literature DB >> 1976221

Role of somatostatin and its analogues in the pathogenesis and treatment of diabetes mellitus.

J E Gerich1.   

Abstract

Somatostatin secreted by pancreatic D cells is a potent inhibitor of insulin, glucagon and growth hormone secretion, as well as other cells. The role of abnormal pancreatic D-cell function in diabetes mellitus is unclear. However, development of long-acting selective somatostatin analogs might prove useful in the treatment of diabetes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1976221     DOI: 10.1016/0026-0495(90)90211-t

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  4 in total

Review 1.  Insulin-dependent (type I) diabetes mellitus.

Authors:  W Rodger
Journal:  CMAJ       Date:  1991-11-15       Impact factor: 8.262

2.  Decreased insulin requirements after LAR-octreotide but not after lanreotide in an acromegalic patient.

Authors:  S M Webb; E Ortega; J Rodríguez-Espinosa; M E Mato; R Corcoy
Journal:  Pituitary       Date:  2001-09       Impact factor: 4.107

3.  Intercellular Communication in the Islet of Langerhans in Health and Disease.

Authors:  Xue W Ng; Yong H Chung; David W Piston
Journal:  Compr Physiol       Date:  2021-06-30       Impact factor: 8.915

4.  Somatostatin secreted by islet delta-cells fulfills multiple roles as a paracrine regulator of islet function.

Authors:  Astrid C Hauge-Evans; Aileen J King; Danielle Carmignac; Carolyn C Richardson; Iain C A F Robinson; Malcolm J Low; Michael R Christie; Shanta J Persaud; Peter M Jones
Journal:  Diabetes       Date:  2008-11-04       Impact factor: 9.461

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.